Ci Investments Inc. Innoviva, Inc. Transaction History

Ci Investments Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$11.39 - $13.72 $45,343 - $54,619	3,981 Added 18.75%	25,213 $321,000
Q1 2023 May 12, 2023	BUY	$10.73 - $13.6 $11,159 - $14,144	1,040 Added 5.15%	21,232 $239,000
Q4 2022 Feb 10, 2023	BUY	$11.8 - $13.78 $238,265 - $278,245	20,192 New	20,192 $268,000

228

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.2B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.